The Blavatnik Family - Chelsea Medical Center at Mount Sinai — New York, New York

The Blavatnik Family - Chelsea Medical Center at Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

The Blavatnik Family - Chelsea Medical Center at Mount Sinai has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Cervical Cancer, Breast Cancer, Ovarian Cancer.

Sponsors: GOG Foundation, Stemline Therapeutics, Inc., K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Blavatnik Family - Chelsea Medical Center at Mount Sinai?

The Blavatnik Family - Chelsea Medical Center at Mount Sinai has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Blavatnik Family - Chelsea Medical Center at Mount Sinai conducted?

The Blavatnik Family - Chelsea Medical Center at Mount Sinai has 5 clinical trials on record, with 3 currently active. Their work covers Cervical Cancer, Breast Cancer, Ovarian Cancer.

Is The Blavatnik Family - Chelsea Medical Center at Mount Sinai accredited by Crixeo Health?

Yes — The Blavatnik Family - Chelsea Medical Center at Mount Sinai holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Blavatnik Family - Chelsea Medical Center at Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.